destinyclinicaltrials.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: | ||
Meta Tags
| Title | DESTINY Clinical Trials for Metastatic Breast |
| Description | Find information on Phase 3 fam- trastuzumab deruxtecan (DS-8201) trials; for eligible patients with metastatic breast |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 40.118.104.64 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
destinyclinicaltrials.com Valuation
|
US$4,091,656
Last updated: 2023-05-18 18:10:20
destinyclinicaltrials.com has Semrush global rank of 2,586,802. destinyclinicaltrials.com has an estimated worth of US$ 4,091,656, based on its estimated Ads revenue. destinyclinicaltrials.com receives approximately 472,115 unique visitors each day. Its web server is located in United States, with IP address 40.118.104.64. According to SiteAdvisor, destinyclinicaltrials.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,091,656 |
| Daily Ads Revenue | US$3,777 |
| Monthly Ads Revenue | US$113,308 |
| Yearly Ads Revenue | US$1,359,689 |
| Daily Unique Visitors | 31,475 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| destinyclinicaltrials.com. 7200 | A | destinyclinicaltrials.com. 7200 | IP: 40.118.104.64 |
| destinyclinicaltrials.com. 7200 | NS | destinyclinicaltrials.com. 7200 | NS Record: ns28.worldnic.com. |
| destinyclinicaltrials.com. 7200 | NS | destinyclinicaltrials.com. 7200 | NS Record: ns27.worldnic.com. |
| destinyclinicaltrials.com. 7200 | TXT | destinyclinicaltrials.com. 7200 | TXT Record: lm7xyjjlglb6pf6sgxv6chrjkrq0lrxt |
HtmlToTextCheckTime:2023-05-18 18:10:20
| Home Trials Locator Understanding Clinical Trials Select another language Deutsch English Español Français Português DESTINY Clinical Trials A series of international trials investigating trastuzumab deruxtecan (T-DXd)* as a potential treatment option for eligible patients with certain cancers, including breast, gastric, lung, and additional cancer types. Select a cancer type to learn more about current clinical trials. Select Cancer Type Breast Gastric Lung Additional Cancer Types Breast Gastric Lung Additional Cancer Types Studies for patients whose primary cancer site originated in the breast. Select a clinical trial below to learn more. DESTINY-Breast05 TRIAL OVERVIEW Official Title: A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Participants With High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast or Axillary Lymph Nodes Following Neoadjuvant |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Type: text/html Content-length: 0 Connection: Close Location: https://www.destinyclinicaltrials.com/ HTTP/1.1 200 OK Cache-Control: no-cache, no-store Pragma: no-cache Content-Length: 135463 Content-Type: text/html; charset=utf-8 Expires: -1 Server: Microsoft-IIS/10.0 Set-Cookie: Cookie_currentUserCity=Helsinki; path=/ Set-Cookie: Cookie_currentUserState=18; path=/ Set-Cookie: ds_dct_unbranded#lang=en; path=/ Set-Cookie: isPopupHome=isPopupHome=isPopup1; expires=Mon, 10-Oct-2022 08:29:05 GMT; path=/ X-Frame-Options: SAMEORIGIN Date: Tue, 12 Jul 2022 08:29:05 GMT Set-Cookie: BNES_Cookie_currentUserCity=qsJPGWXDDZhJKuvF1hsxinkoT+6ua8BzHrWxfQJFyJcj3xWV9Evk2V0acS/eBX8exHq1eCEfgr8L1r4n/r+dMl+UHGRTPuogSVpUqoJ6KFY=; path=/ Set-Cookie: BNES_Cookie_currentUserState=aB8UMR7EtmQ0g9bR0RAfgbgQZcaOVPTg9e0M3mUxxi1FchyP/ZDVFEbirh5lEkuHRSesUvN+KcnbKKJi2JrmjTfNclR7RSlF; path=/ Set-Cookie: BNES_ds_dct_unbranded#lang=IiKpILnX7F61y+jt+lYUFKRWnH3trCYMMFFD8h+FC3sRNLRrLvyvSOWVBRHC0g1ScMcbYLq0YgU26aE9076HSSI3Lq3/eCWD; path=/ Set-Cookie: BNES_isPopupHome=5T/E+e8U53gWjUC2MCeyb5QdSdCEAKuObSKjjybo57fwDqkPYUhT49avoLZauY+CvlmyV6o3fAt8gTNqCiv/RgG07V7VhLsGzX5EOFPDpV8=; expires=Mon, 10-Oct-2022 08:29:05 GMT; path=/ |
destinyclinicaltrials.com Whois Information
Domain Name: DESTINYCLINICALTRIALS.COM Registry Domain ID: 2403113696_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2022-06-02T16:47:27Z Creation Date: 2019-06-17T17:45:48Z Registry Expiry Date: 2025-06-17T17:45:48Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS27.WORLDNIC.COM Name Server: NS28.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2022-07-12T08:25:53Z <<< |